These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37626419)

  • 1. DARS2 overexpression is associated with PET/CT metabolic parameters and affects glycolytic activity in lung adenocarcinoma.
    Liu XS; Yuan LL; Gao Y; Ming X; Zhang YH; Zhang Y; Liu ZY; Yang Y; Pei ZJ
    J Transl Med; 2023 Aug; 21(1):574. PubMed ID: 37626419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SFXN1 as a potential diagnostic and prognostic biomarker of LUAD is associated with
    Zhang YH; Liu XS; Gao Y; Yuan LL; Huang ZM; Zhang Y; Liu ZY; Yang Y; Liu XY; Ke CB; Pei ZJ
    Lung Cancer; 2024 Feb; 188():107449. PubMed ID: 38184958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleophosmin 1 overexpression correlates with
    Zhou LM; Yuan LL; Gao Y; Liu XS; Dai Q; Yang JW; Pei ZJ
    Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):904-912. PubMed ID: 32856112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced glucose metabolism mediated by CD147 is associated with
    Zhang Y; Liu J; Sun Y; Yu X; Wang J; Dai D; Zhu Y; Song X; Zhu L; Li X; Xu W
    Thorac Cancer; 2020 May; 11(5):1245-1257. PubMed ID: 32162491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of volume-based 18F-FDG PET/CT parameters and correlation with PD-L1 expression in patients with surgically resected lung adenocarcinoma.
    Wang D; Li Y; Chen X; Li P
    Medicine (Baltimore); 2021 Sep; 100(35):e27100. PubMed ID: 34477147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Semiquantitative parameters of
    Liao XH; Wang RF; Liu M; Chen XQ; Xiong Y; Nong L; Yin L; Zhang BY; DU YJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 53(2):246-254. PubMed ID: 33879893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA (let-7b-5p)-targeted DARS2 regulates lung adenocarcinoma growth by PI3K/AKT signaling pathway.
    Xu Y; Chen X
    Oncol Res; 2024; 32(3):517-528. PubMed ID: 38361754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of intratumor metabolic and heterogeneity parameters on [
    Ni M; Wang S; Liu X; Shi Q; Zhu X; Zhang Y; Xie Q; Lv W
    Jpn J Radiol; 2023 Feb; 41(2):209-218. PubMed ID: 36219311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volumetric PET parameters can predict overall survival in advanced lung adenocarcinoma.
    Yanarateş A; Yazici B
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(1):3-8. PubMed ID: 31818695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of 18F-FDG PET/CT Metabolic Parameters in Surgically Treated Stage I Lung Adenocarcinoma Patients.
    Tosi D; Pieropan S; Cattoni M; Bonitta G; Franzi S; Mendogni P; Imperatori A; Rotolo N; Castellani M; Cuzzocrea M; Schiorlin I; Casagrande S; De Palma D; Nosotti M; Dominioni L
    Clin Nucl Med; 2021 Aug; 46(8):621-626. PubMed ID: 34034316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-FDG PET/CT and circulating tumor cells in treatment-naive patients with non-small-cell lung cancer.
    Zhang F; Wu X; Zhu J; Huang Y; Song X; Jiang L
    Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3250-3259. PubMed ID: 33630146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of DARS2 indicates poor prognosis in lung adenocarcinoma.
    Jiang Y; You J; Wu C; Kang Y; Chen F; Chen L; Wu W
    J Clin Lab Anal; 2022 Oct; 36(10):e24691. PubMed ID: 36085578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents.
    Hwang SH; Cho A; Yun M; Choi YD; Rha SY; Kang WJ
    Clin Nucl Med; 2017 May; 42(5):e235-e241. PubMed ID: 28288043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDG PET/CT metabolic tumor volume and total lesion glycolysis predict prognosis in patients with advanced lung adenocarcinoma.
    Chung HW; Lee KY; Kim HJ; Kim WS; So Y
    J Cancer Res Clin Oncol; 2014 Jan; 140(1):89-98. PubMed ID: 24194352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The correlation of
    Qu YH; Long N; Ran C; Sun J
    Clin Transl Oncol; 2021 Mar; 23(3):620-627. PubMed ID: 32683540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DARS2 promotes the occurrence of lung adenocarcinoma via the ERK/c-Myc signaling pathway.
    Fang T; Jiang J; Yu W; Li R; Tian H
    Thorac Cancer; 2023 Dec; 14(36):3511-3521. PubMed ID: 37950542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insight on the correlation of metabolic status on
    Wang Y; Zhao N; Wu Z; Pan N; Shen X; Liu T; Wei F; You J; Xu W; Ren X
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1127-1136. PubMed ID: 31502013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of Volumetric Metabolic Parameters on Preoperative FDG PET/CT for Predicting Tumor Lymphovascular Invasion in Non-Small Cell Lung Cancer.
    Li C; Tian Y; Shen Y; Wen B; He Y
    AJR Am J Roentgenol; 2021 Dec; 217(6):1433-1443. PubMed ID: 33978465
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluate the value of (18)F-FDG PET-CT imaging in predicting the mutationsin epidermal growth factor receptor in lung adenocarcinoma].
    Ding CY; Yang WP; Guo Z; Sun J; Li YY; Li TR
    Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):528-531. PubMed ID: 28728300
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation study on 18F-FDG PET/CT metabolic characteristics of primary lesion with clinical stage in lung cancer.
    Hu WD; Wang HC; Wang YB; Cui LL; Chen XH
    Q J Nucl Med Mol Imaging; 2021 Jun; 65(2):172-177. PubMed ID: 30916535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.